PT1776947E - Formulação estável de oxaliplatina - Google Patents
Formulação estável de oxaliplatina Download PDFInfo
- Publication number
- PT1776947E PT1776947E PT06254598T PT06254598T PT1776947E PT 1776947 E PT1776947 E PT 1776947E PT 06254598 T PT06254598 T PT 06254598T PT 06254598 T PT06254598 T PT 06254598T PT 1776947 E PT1776947 E PT 1776947E
- Authority
- PT
- Portugal
- Prior art keywords
- solution
- oxaliplatin
- carbohydrate
- amount
- pharmaceutical composition
- Prior art date
Links
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 title abstract 3
- 229960001756 oxaliplatin Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 239000004411 aluminium Substances 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN809KO2005 | 2005-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1776947E true PT1776947E (pt) | 2008-10-31 |
Family
ID=37745604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT06254598T PT1776947E (pt) | 2005-09-05 | 2006-09-04 | Formulação estável de oxaliplatina |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7674824B2 (pt) |
| EP (1) | EP1776947B1 (pt) |
| AT (1) | ATE401862T1 (pt) |
| DE (1) | DE602006001917D1 (pt) |
| ES (1) | ES2311268T3 (pt) |
| PT (1) | PT1776947E (pt) |
| WO (1) | WO2007029268A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007061763A1 (de) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
| JP5963156B1 (ja) * | 2016-03-23 | 2016-08-03 | テバ製薬株式会社 | オキサリプラチンを含む水性医薬組成物の製造方法及び安定化方法 |
| US11975047B1 (en) | 2022-10-28 | 2024-05-07 | Ani Pharmaceuticals, Inc. | Methods for storing and warming purified corticotropin compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6041077B2 (ja) | 1976-09-06 | 1985-09-13 | 喜徳 喜谷 | １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体 |
| KR100365171B1 (ko) | 1994-08-08 | 2003-02-19 | 드바이오팜 에스.아. | 약학적으로안정한옥살리플라티늄제제 |
| GB9804013D0 (en) * | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
| US6378714B1 (en) * | 1998-04-20 | 2002-04-30 | Becton Dickinson And Company | Transferset for vials and other medical containers |
| BRPI0013613B8 (pt) * | 1999-08-30 | 2021-05-25 | Debiopharm Sa | composição farmacêuticamente estável de oxaliplatina para administração parenteral. |
| WO2003004505A1 (en) * | 2001-07-02 | 2003-01-16 | Debiopharm S.A. | Oxaliplatin active substance with a very low content of oxalic acid |
| US6476068B1 (en) * | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| DE10314377A1 (de) | 2003-03-28 | 2004-10-07 | Stada Arzneimittel Ag | Gebrauchsfertige Oxaliplatin-Lösungen |
| WO2005020980A1 (en) | 2003-08-28 | 2005-03-10 | Mayne Pharma Pty Ltd | Acid containing oxaliplatin formulations |
-
2006
- 2006-08-31 WO PCT/IN2006/000320 patent/WO2007029268A2/en active Application Filing
- 2006-09-04 AT AT06254598T patent/ATE401862T1/de not_active IP Right Cessation
- 2006-09-04 DE DE602006001917T patent/DE602006001917D1/de not_active Expired - Fee Related
- 2006-09-04 ES ES06254598T patent/ES2311268T3/es active Active
- 2006-09-04 EP EP06254598A patent/EP1776947B1/en not_active Not-in-force
- 2006-09-04 PT PT06254598T patent/PT1776947E/pt unknown
- 2006-09-05 US US11/515,553 patent/US7674824B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1776947B1 (en) | 2008-07-23 |
| WO2007029268A3 (en) | 2007-05-31 |
| US7674824B2 (en) | 2010-03-09 |
| WO2007029268B1 (en) | 2007-07-12 |
| ATE401862T1 (de) | 2008-08-15 |
| US20070054957A1 (en) | 2007-03-08 |
| EP1776947A1 (en) | 2007-04-25 |
| WO2007029268A2 (en) | 2007-03-15 |
| DE602006001917D1 (de) | 2008-09-04 |
| ES2311268T3 (es) | 2009-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2494825A1 (en) | Injectable pharmaceutical suspension in a two-chamber vial | |
| PT1389089E (pt) | Processo e composição para solubilizar um composto biologicamente activo com uma baixa solubilidade em água | |
| BR0309894A (pt) | Composição, processo para preparar uma composição de celulose microcristalina, produto alimentìcio, composição farmacêutica, composição cosmética, forma de dosagem farmacêutica, e, composição industrial | |
| WO2007005633A3 (en) | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate | |
| DE602005024800D1 (de) | Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff | |
| CA2411918A1 (en) | Cubic liquid crystalline compositions and methods for their preparation | |
| BRPI0410679A (pt) | fórmulas de proteìna lìquida estabilizada em conteiners farmacêuticos cobertos | |
| TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
| AR056835A1 (es) | Composicion que contiene oligosacaridos | |
| PT1776947E (pt) | Formulação estável de oxaliplatina | |
| RU2010154545A (ru) | Фармацевтическая композиция, содержащая фторхинолоновое антибиотическое лекарственное средство | |
| ZA200805598B (en) | Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid | |
| MY121175A (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
| CN102971072A (zh) | 水至除氧剂的受控释放 | |
| CN103374343A (zh) | 调剖驱油用吸水膨胀材料及其生产方法 | |
| WO2020029443A1 (zh) | 一种盐酸替罗非班注射液及其制备方法 | |
| RU2010108161A (ru) | Двухкомпонентные глазные капли, содержащие пиреноксин | |
| CL2009000960A1 (es) | Dispersion acuosa de particulas que contienen fructano, donde el d50 de las particulas de 2-50um y un 61%-80% p/p de materia solida; proceso de elboracion que comprende mezclar fructano y agua, opcionalmente hidrolizar hasta 5-25% p/p de fructanos no solubles, opcionalmente purificar, concentrar hasta un 61-80% p/p de materia solida. | |
| WO2003068247A1 (en) | Eye installation based on iodine anions | |
| CN102973569A (zh) | 一种头孢米诺钠无菌混合粉形式的药物组合物 | |
| CA2534259A1 (en) | Glycyrrhizin high-concentration preparation | |
| KR102415182B1 (ko) | 결정성 l-카르노신 아연 착체의 보존 용기 및 보존 방법 | |
| WO2007035448A3 (en) | Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses | |
| KR101779676B1 (ko) | 균일한 혼합도의 투석액 조제용 조성물의 제조방법 | |
| UA90013C2 (ru) | Фармацевтическая композиция, содержащая инсулин, и способ его получения |